TYROSINE KINASE INHIBITORS (TKI) FOR THE TREATMENT OF ADVANCED MEDULLARY THYROID CARCINOMA: A SYSTEMATIC REVIEW AND INDIRECT COMPARISON

被引：0
|
作者：
Kawalec, P. [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Krakow, Poland
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN4
引用
收藏
页码：A708 / A708
页数：1
相关论文
共 50 条
  • [1] Kinase inhibitors for advanced medullary thyroid carcinoma
    Schlumberger, Martin
    Massicotte, Marie-Helene
    Nascimento, Camila L.
    Chougnet, Cecile
    Baudin, Eric
    Leboulleux, Sophie
    CLINICS, 2012, 67 : 125 - 129
  • [2] Management of advanced stage medullary thyroid carcinoma. Therapy with tyrosine kinase inhibitors
    Raue, F.
    Fassnacht, M.
    Fuehrer, D.
    Frank-Raue, K.
    Luster, M.
    Kreissl, M. C.
    Mueller, S.
    Musholt, T.
    Ruessel, J.
    Schott, M.
    Spitzweg, C.
    Tiedje, V.
    ONKOLOGE, 2014, 20 (06): : 591 - 597
  • [3] Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients
    Resteghini, C.
    Cavalieri, S.
    Galbiati, D.
    Granata, R.
    Alfieri, S.
    Bergamini, C.
    Bossi, P.
    Licitra, L.
    Locati, L. D.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 31 (03) : 349 - 361
  • [4] Use of Tyrosine-Kinase Inhibitors in Medullary Thyroid Carcinoma: An Institutional Experience
    Luca, R.
    O'Connor, J. M.
    Falco, A.
    Do Pico, F.
    Tsou, F.
    Rivero, S.
    Chacon, M.
    Chacon, R.
    NEUROENDOCRINOLOGY, 2017, 105 : 218 - 218
  • [5] Therapeutic management of metastatic medullary thyroid carcinoma: Role of new tyrosine kinase inhibitors
    Garcia-Martin, Antonia
    Lopez-Ibarra Lozano, Pablo Jose
    Maria Trivino-Ibanez, Eva
    Escobar-Jimenez, Fernando
    ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (03): : 152 - 153
  • [6] RESPONSE AND RESISTANCE TO THE RECEPTOR TYROSINE KINASE INHIBITOR (TKI) VANDETANIB IN PEDIATRIC PATIENTS WITH MEDULLARY THYROID CARCINOMA (MTC)
    Akshintala, Srivandana
    Dombi, Eva
    Glod, John
    Fox, Elizabeth
    Lodish, Maya
    Whitcomb, Patricia
    Balis, Frank
    Widemann, Brigitte
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 102 - 102
  • [7] Chemotherapy and tyrosine-kinase inhibitors for medullary thyroid cancer
    Hadoux, Julien
    Schlumberger, Martin
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 31 (03) : 335 - 347
  • [8] A Tyrosine-kinase inhibitors (TKIs) treatment in sporadic Medullary Thyroid Cancer in a boy
    Cau, Ana Carolina Arias
    Cosentini, Maria Luz
    Alderete, Silvana
    Viso, Rene
    Gazek, Natalia
    Ayarzabal, Victor Hugo
    Dujovne, Noelia Vanesa
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 2): : 137 - 138
  • [9] How to Incorporate New Tyrosine Kinase Inhibitors in the Treatment of Patients With Medullary Thyroid Cancer
    Haddad, Robert I.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) : 3618 - 3620
  • [10] ROLE OF TYROSINE KINASE INHIBITORS IN CHILDREN WITH MEN2 ASSOCIATED MEDULLARY THYROID CARCINOMA
    Myers, Katherine
    Akshintala, Srivandana
    Del Rivero, Jaydira
    Walker, Kim
    Widemann, Brigitte
    Glod, John
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S115 - S116
12345